Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway

被引:36
作者
Carr, DJJ
Al-Khatib, K
James, CM
Silverman, R
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA
[3] Murdoch Univ, Div Hlth Sci, Murdoch, WA 6150, Australia
[4] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol NB40, Cleveland, OH 44195 USA
关键词
IFN-alpha; IFN-beta; HSV-1; PKR; OAS; neuroimmunology;
D O I
10.1016/S0165-5728(03)00216-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The induction of an antiviral state by type I interferons (IFN) was evaluated in primary trigeminal ganglion cell cultures using herpes simplex virus type 1 (HSV-1). Cells treated with mouse IFN-beta consistently showed the greatest resistance to HSV-1 infection in comparison to cells treated with IFN-alpha1, IFN-alpha4, IFN-alpha5, IFN-alpha6, or IFN-alpha9. The antiviral efficacy was dose-dependent and correlated with the induction of the IFN-inducible, antiviral genes, 2'-5' oligoadenylate synthetase (OAS) and double-stranded RNA-dependent protein kinase. In trigeminal ganglion cells deficient in the downstream effector molecule of the OAS pathway, RNase L, the antiviral state induced by IFN-beta was lost. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 43 条
  • [1] The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-β-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture
    Al-Khatib, K
    Williams, BRG
    Silverman, RH
    Halford, W
    Carr, DJJ
    [J]. VIROLOGY, 2003, 313 (01) : 126 - 135
  • [2] Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-β
    Al-Khatib, K
    Williams, BRG
    Silverman, RH
    Halford, WP
    Carr, DJJ
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (08) : 861 - 871
  • [3] Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection
    Bartlett, EJ
    Cull, VS
    Brekalo, NL
    Lenzo, JC
    James, CM
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (05) : 425 - 435
  • [4] Cytokine and chemokine production in HSV-1 latently infected trigeminal ganglion cell cultures: Effects of hyperthermic stress
    Carr, DJJ
    Noisakran, S
    Halford, WP
    Lukacs, N
    Asensio, V
    Campbell, IL
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (02) : 111 - 121
  • [5] ACTIVATION OF THE PPP(A2'P)NA SYSTEM IN INTERFERON-TREATED, HERPES-SIMPLEX VIRUS-INFECTED CELLS AND EVIDENCE FOR NOVEL INHIBITORS OF THE PPP(A2'P)NA-DEPENDENT RNASE
    CAYLEY, PJ
    DAVIES, JA
    MCCULLAGH, KG
    KERR, IM
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1984, 143 (01): : 165 - 174
  • [6] Val193 and Phe195 of the γ134.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-α/β
    Cheng, GF
    Brett, ME
    He, B
    [J]. VIROLOGY, 2001, 290 (01) : 115 - 120
  • [7] ASSOCIATION OF A M(R)-90,000 PHOSPHOPROTEIN WITH PROTEIN-KINASE PKR IN CELLS EXHIBITING ENHANCED PHOSPHORYLATION OF TRANSLATION INITIATION-FACTOR EIF-2-ALPHA AND PREMATURE SHUTOFF OF PROTEIN-SYNTHESIS AFTER INFECTION WITH GAMMA(1)34.5(-) MUTANTS OF HERPES-SIMPLEX-VIRUS-1
    CHOU, J
    CHEN, JJ
    GROSS, M
    ROIZMAN, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10516 - 10520
  • [8] INHIBITION OF CELL-FREE PROTEIN-SYNTHESIS BY PPPA2'P5'A2'P5'A - NOVEL OLIGONUCLEOTIDE SYNTHESIZED BY INTERFERON-TREATED L-CELL EXTRACTS
    CLEMENS, MJ
    WILLIAMS, BRG
    [J]. CELL, 1978, 13 (03) : 565 - 572
  • [9] THYMIDINE KINASE-NEGATIVE HERPES-SIMPLEX VIRUS MUTANTS ESTABLISH LATENCY IN MOUSE TRIGEMINAL GANGLIA BUT DO NOT REACTIVATE
    COEN, DM
    KOSZVNENCHAK, M
    JACOBSON, JG
    LEIB, DA
    BOGARD, CL
    SCHAFFER, PA
    TYLER, KL
    KNIPE, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) : 4736 - 4740
  • [10] Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
    Cull, VS
    Bartlett, EJ
    James, CM
    [J]. IMMUNOLOGY, 2002, 106 (03) : 428 - 437